Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 700 of 6351
-
HIV-Positive hearts for HIV-Positive patients: a lifesaving experiment?
Disease control Recruiting nowThis will be a prospective single-center interventional trial to compare the outcomes of HIV-positive heart transplant recipients by the HIV status of the donor; HIV-positive vs. HIV-negative and learn whether heart organ transplantation from HIV+ deceased donors is as safe and e…
Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Could a common ADHD drug tame attention issues in rare KBG syndrome?
Disease control Recruiting nowThe goal of this clinical trial\] is to learn about the effect of methylphenidate in children and adolescents with KBG syndrome. The main question it aims to answer is: • What is the effectiveness of methylphenidate on attention deficit and ADHD-related symptoms in children and …
Phase 4 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can we predict frailty in serious illness? a large study investigates
Knowledge-focused Recruiting nowThe objective of this prospective multicentre study that recruits altogether 1500 older patients from the university hospitals of Tampere, Kuopio, and Oulu is to explore the clinical significance and detection of causes of generalized vulnerability. The objectives are: O1 - Esta…
Sponsor: Tampere University Hospital • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
New liposomal combo aims to control advanced colorectal cancer
Disease control Recruiting nowGuidelines recommend FOLFIRI in combination with bevacizumab or cetuximab as a treatment option for advanced second-line colorectal cancer, and this study explores the efficacy and safety of a clinical study of liposomal irinotecan (II), fluorouracil, in combination with bevacizu…
Phase 2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New shigella vaccine shows promise in human trial
Vaccine OngoingIn this challenge study, the bioconjugate candidate vaccine Shigella4V2 will be tested for its ability to induce an immune response that protects healthy adult volunteers from infection with a wild-type Shigella sonnei strain compared to participants receiving placebo.
Phase 2 • Sponsor: LimmaTech Biologics AG • Aim: Vaccine
Last updated Jul 18, 2026 00:00 UTC
-
New iron injection shows promise in shrinking tumors
Disease control Recruiting nowIndependently developed by Sichuan Yingrui Pharmaceutical Technology Co., Ltd., CNSI-Fe is an innovative anti-cancer drug with Fe2+ as the active ingredient, which exerts anti-tumor effects by regulating the ferroptosis pathway. CNSI-Fe intratumoral injection has the following th…
Phase 1/2 • Sponsor: Sichuan Enray Pharmaceutical Sciences Company • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New GBS vaccine trial aims to shield mothers and newborns
Vaccine OngoingTo assess the safety and tolerability of IVT GBS-06 vaccine administered as a single-dose regimen, at three dosage levels in healthy, non-pregnant, adult women of childbearing age (WOCBA).
Phase 1/2 • Sponsor: Inventprise Inc. • Aim: Vaccine
Last updated Jun 27, 2026 07:58 UTC
-
Can precision radiation delay cancer spread? new trial aims to find out
Disease control Recruiting nowThis is a Phase III non-blinded randomized study evaluating patients with oligometastatic cancers (up to 10 metastases). Subjects are randomized 1:1 to stereotactic ablative radiotherapy (SABR) plus standard of care therapies versus standard of care therapies alone. The investiga…
Phase 3 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New particle beam therapy targets stubborn liver tumors
Disease control Recruiting nowThis is a prospective, single-arm Phase II study designed to evaluate the safety and efficacy of carbon ion radiotherapy in patients with hepatocellular carcinoma (HCC) who demonstrate residual or recurrent disease after prior transarterial radioembolization (TARE). Carbon ion ra…
Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New Clot-Busting device could change stroke care
Disease control Recruiting nowThe main objective of this clinical trial is to evaluate of the safety \& efficacy of the Ceretrieve device within 24 hours post thrombectomy procedure. This means to assess that the use with the Ceretrieve neuro-thrombectomy device that is designed to treat acute ischemic stroke…
Sponsor: Ceretrieve Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could High-Intensity workouts and diet tame chest pain from tiny heart vessels?
Symptom relief Recruiting nowThe goal of this clinical trial is to assess the feasibility of undertaking a randomized controlled trial assessing the impact of a personalised, intense cardiac rehabilitation programme involving high intensity interval exercise (HIIT) and dietary advice (termed MICROFIT) on sym…
Sponsor: Royal United Hospitals Bath NHS Foundation Trust • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Could a common diabetes drug weaken or protect aging muscles?
Knowledge-focused CompletedWith the accelerating aging process in China, sarcopenia has drawn increasing attention. Sarcopenia is an age-related geriatric syndrome characterized by reductions in muscle mass, muscle strength, and/or physical function. Sarcopenia has a high prevalence, often insidious onset,…
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC
-
Double defense: new mRNA vaccine targets two lung viruses in seniors
Vaccine OngoingThe aim of this study is to evaluate the safety and immunogenicity of a human metapneumovirus (hMPV) / respiratory syncytial virus (RSV) mRNA vaccine candidate encapsulated in a lipid nanoparticle (LNP) based formulation (hereafter referred to as hMPV/RSV vaccine) for the prevent…
Phase 1/2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Vaccine
Last updated Jun 27, 2026 08:03 UTC
-
Gene therapy for deafness: researchers track long-term safety and hearing gains
Disease control By invitation onlyThis multi-center, observational, post-intervention long term follow-up (LTFU) study will monitor for safety and efficacy of AAVAnc80-hOTOF in individuals with sensorineural hearing loss due to otoferlin gene mutations who have previously received intracochlear administration of …
Sponsor: Akouos, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Brain imaging may reveal who benefits from deep brain stimulation for Parkinson's freezing
Knowledge-focused Recruiting nowFor this study, the investigators are recruiting 54 individuals with Parkinson's Disease and Freezing of Gait (FOG) who are planning to undergo Deep Brain Stimulation (DBS). The objective of this study is to better understand the FOG response to DBS. Prior to DBS, participants wi…
Phase 4 • Sponsor: Medical University of South Carolina • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
New hope for Hard-to-Treat seizures: phase 3 trial launches
Disease control OngoingThis (DEEp OCEAN Study) is a double-blind, randomized, placebo-controlled, multicenter study to investigate the efficacy, safety, and tolerability of LP352 in the treatment of seizures in children and adults with DEE. The study consists of 3 main phases: Screening, Titration peri…
Phase 3 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Which comes first? a trial tests the best sequence for lung nodule biopsies.
Knowledge-focused Recruiting nowThis study will randomize participants undergoing a bronchoscopic biopsy of a peripheral pulmonary nodule for their standard of care to receive robotic-assisted bronchoscopy (RaB) and then staging linear endobronchial ultrasounnd (EBUS) OR staging linear EBUS first, followed by R…
Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
New drug could tame deadly immune storm in kids before transplant
Disease control Recruiting nowThe purpose of this project is to study the survival of patients until Haematopoietic Stem Cell Transplantation following the use of Ruxolitinib as first-line treatment associated to corticosteroids in primary HLH.
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can gentle electrical pulses revive damaged nerves in diabetes?
Symptom relief CompletedThis study will be carried out on 60 patients both gender male and female with diabetic neuropathy with age55-65 years. The patients will be selected from Elmahmoudia hospital .patients will be randomly assigned to two groups.
Sponsor: Cairo University • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
Engineered immune cells take on lupus and scleroderma in early trial
Disease control By invitation onlyADI-202300103 is a phase 1 multicenter, open label, dose finding and dose expansion, safety/efficacy study in patients with autoimmune disease. The study will consist of different periods including screening, lymphodepletion, treatment, and follow-up
Phase 1 • Sponsor: Adicet Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC